We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)
  • Gowling Lafleur Henderson LLP
  • Canada
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection


Be warned: online forum selection clauses may oblige you to litigate abroad
  • Gowling Lafleur Henderson LLP
  • Canada
  • June 30 2015

The decision in Douez v. Facebook, Inc., provides some comfort to online businesses that rely upon forum selection clauses in their online contracts


AstraZeneca v. Novopharm, appeal of decision to strike Statement of Claim
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes to strike AstraZeneca's Statement of Claim


Apotex loses the war in Canada and the battle in England: UK courts rely on Canadian decision to find Apotex acting unlawfully in cCnada has consequences in eErope
  • Gowling Lafleur Henderson LLP
  • Canada, United Kingdom
  • October 13 2011

Servier developed perindopril erbumine (“perindopril”) which is a successful long lasting ACE inhibitor sold under the trade-mark COVERSYL


AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing


Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary
  • Gowling Lafleur Henderson LLP
  • Canada
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary


Counterfeiters face stiff penalties in Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • February 10 2014

The Office of the United States Trade Representative ("USTR") publishes a report every few years called the Special 301 Report. In the report, the


Pfizer v Ratiopharm, PMNOC Regulations decision, sildenafil citrate, June 8, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

The Court dismissed an application for an order of prohibition under the PMNOC Regulations, wherein ratiopharm sought a generic version of the drug Revatio containing sildenafil citrate (the active ingredient in Viagra) until after the expiry of a Pfizer patent


Astrazeneca v. Apotex, PMNOC Regulations decision, esomeprazole, June 30, 2010
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 16 2010

The court dismissed AstraZeneca's application AstraZeneca for an order prohibiting the issuance of a Notice of Compliance ("NOC") to Apotex on the grounds that the allegation of invalidity was justified insofar as the assertions of lack of utilitysound prediction and obviousness, but not justified regarding an assertion of anticipation


Impacts of the Amazon.com decisions on medical use claims in Canada
  • Gowling Lafleur Henderson LLP
  • Canada
  • July 13 2012

Methods of medical treatment and surgery are not statutory subject matter in Canada